CGMP for Biopharmaceutical Drug Products

CGMP badge

Course Description

This lecture-based, three-hour virtual course covers 21 CFR Parts 210, 211, and 600. Topics include Current Good Manufacturing Practices (CGMPs), regulatory compliance, and maintaining a culture of quality for the safe manufacture of biopharmaceutical drug products. Participants learn the core precepts of FDA’s Current Good Manufacturing Practices and their direct application to the manufacture and testing of a regulated biological product.

Learning Objectives

· Understand the purpose and impact of CGMP protocols and regulatory compliance
· Recall the history of CGMP and the role of FDA
· Recognize legislation, definitions, and critical components of CGMP in biological drug development
· Comprehend FDA CGMP Regulations as defined in 21 CFR 210, 211, and 600

Learn more and register:

Biotility at the University of Florida is committed to providing high-quality education and training to facilitate the professional growth of each participant. Our short-courses are attended by professionals, students preparing to enter industry careers, and researchers, all of whom seek to expand and deepen their knowledge in technical and regulatory details unique to biotechnology industries and translational research.